We Are Here’s Post

This is why I do what I do: to help move the needle on truly important, impactful work such as that performed by the American Cancer Society. To support this mission, *and* engage in a deep dialogue with thought leaders, makes me quite fortunate. #impactinvesting #sustainablefinance #holtara

🔬 2024 FRANCE TISSUE BANK'S ANNUAL REPORT Dear partners and collaborators, As we conclude 2024 we wanted to share with you the outcome of this wonderful year. Nothing could have been realized without you, our partnerships and the sharing of knowledge realized everyday. Our unwavering commitment to cancer therapeutic research has continued to guide our actions, solidifying our position as a crucial gateway between innovators and essential resources. 🙏 A greeatful thank to our partners, collaborators, and dedicated teams who made all of this possible. 2024 was a year filled with overcome challenges, fruitful partnerships, and meaningful contributions to cancer research. As we turn the page towards 2025, our commitment to scientific advancement remains stronger than ever. Together, let's continue advancing the fight against cancer. #FranceTissueBank #CancerResearch #2024review #Biobanking💙🧬

🎧 {NEW} We're giving you a challenge: to spark joy and strengthen connections within your teams and communities over the next 90 days. Through intentional acts of celebration and connection, we explore the transformative power of shared experiences in fostering a sense of belonging and support. As part of this journey, the Leadership Vision team shares their participation in a deeply meaningful 5k race for breast cancer awareness, marking a tradition of resilience and unity. This episode exemplifies how collective actions can significantly impact our sense of community and belonging. 🔗 Join us in embracing this challenge to create lasting, positive change. https://buff.ly/3U8e6Si

Traveling back from 2025 leadership conference convinced that we placed solid foundation with a great strategy, and “yes” we are on the right side of the battle against cancer: “Advancing Cancer Diagnostics, Improving Lives”.

We're at the National Cancer Congress Malaysia! 🇲🇾 We're excited to be participating in the National Cancer Congress Malaysia starting today and running until Sunday! Come visit us at booth B9 to learn more about our solutions. Don't miss this opportunity to connect with us and other leading experts in the field! #agtcgenomics #NCCM2024 #sunwayuniversity #CancerGenomics #CancerRiskDx #CancerScreenDx #PreciseDx #LiquidDx #CancerTRACE #Cancercare #ComprehensiveGenomicProfiling

The University of Pittsburgh Office of Innovation and Entrepreneurship is here to help you learn more about resources for commercialization and startup creation!  On July 10, join this webinar to learn more about The National Institutes of Health's SBIR/STTR programs; tips for writing competitive SBIR/STTR grant proposals; funding opportunities for startups, academic spinout companies, and early-stage academic entrepreneurs; and commercialization resources for applicants and awardees. https://lnkd.in/eGW_QZZJ

Curebound announced its final wave of 2024 grants this week. Our Scientific Advisory Board unanimously selected 9 Discovery and 8 Targeted Grants - 17 exceptional research teams, all in studying 15 different types of cancer. Building upon the Equity and Catalyst Grants awarded earlier this year, we are very proud to end the year with a comprehensive commitment of $8.25 million in innovative cancer research. View the portfolio via: https://lnkd.in/dxKPWtKG UC San Diego Health Rady Children's Hospital-San Diego Scripps Research Salk Institute for Biological Studies Sanford Burnham Prebys

🚀 #SITC24 kicks off tomorrow in Houston, and ANIM8 LLC is excited to be on the ground, diving into cutting-edge advancements in Immuno-Oncology! 🎯 Cancer is a global challenge that won't be solved by one clinical trial or a single company — collaboration is the key to unlocking breakthroughs. That's why we're here to connect with the brightest minds across the IO space to help accelerate progress toward next-generation anticancer therapies. Our CEO & Founder, Raphaël G. Ognar, MSc MBA, and CMO, Debora Barton, MD, will be in the heart of the action. 🤝 If you're attending #SITC24, let’s meet up and explore how we can push the fast forward button on the fight against cancer! 💡 Together, we can make a difference. Let’s ensure that your next step is the right one on the path to success. 🔗 DM us to schedule a meeting, or simply drop a comment below—we’d love to connect! 👇 #ImmunoOncology #CancerResearch #CollaborationForCures #BiotechInnovation #Oncology #SITC2024 #CellAndGeneTherapy

Scientists learn early on that when an experiment doesn’t deliver the expected results, we should not be discouraged - we should be motivated to take what we learn from that experience and try again. I’m grateful to have had the opportunity to talk about the importance of resilience in oncology research and specifically in gastrointestinal cancers – an area of high unmet need – and how taking risks is key to achieving improvements in care for patients: https://learn.az/6048ouZ8G

Our recently-published Impact Report showcases the broad-ranging impacts made by OICR-affiliated scientists, clinicians and patient partners over the past year – what they mean for now and what they mean for the future. It shows how our collective efforts, as Ontario’s cancer research institute, are delivering on our commitment to improve the lives of people today, as well as future generations. https://lnkd.in/eVD3QP4